Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Byline Bancorp Q4 EPS $0.65 Beats $0.59 Estimate

Byline Bancorp (NYSE:BY) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.59 by 10.17 percent. This is a 5.8 percent decrease over earnings of $0.69 per share from the same
byBenzinga Newsdesk
January 26, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Byline Bancorp (NYSE:BY) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.59 by 10.17 percent. This is a 5.8 percent decrease over earnings of $0.69 per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

AstraZeneca Announced Lynparza Approved in China for Ovarian Cancer

By Charles Gross
September 22, 4:49 AM
AstraZeneca and MSD's Lynparza (olaparib) has been approved in China for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to 1st-line platinum-based chemotherapy in combination with bevacizumab, and whose cancer is associated with homologous recombination deficiency (HRD)-positive statu

AZN